Insider: MILLER RICHARD A MD President and CEO - Corvus Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 577,634 | 1,490,119 | 2,067,753 |
| Value | $4,008,779.96 | $10,341,425.86 | $14,350,205.82 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/06/2024 | AAP | 577,634 | Direct | COM | $1.73 | $999,999.98 | 577,634 |
| 12/14/2022 | AAP | 10,000 | Indirect | COM | $0.78 | $7,812.00 | 1,490,119 |
| 12/13/2022 | AAP | 50,000 | Indirect | COM | $0.74 | $37,015.00 | 1,480,119 |
| 09/28/2022 | AAP | 25,000 | Indirect | COM | $0.76 | $19,070.00 | 1,394,405 |
| 09/20/2022 | AAP | 12,300 | Indirect | COM | $0.81 | $9,964.23 | 1,361,705 |
| 09/20/2022 | AAP | 5,000 | Indirect | COM | $0.82 | $4,075.00 | 1,369,405 |
| 09/20/2022 | AAP | 2,700 | Indirect | COM | $0.82 | $2,214.00 | 1,364,405 |
| 06/27/2022 | AAP | 5,000 | Indirect | COM | $1.00 | $4,984.50 | 1,349,405 |
| 06/24/2022 | AAP | 5,000 | Indirect | COM | $1.03 | $5,150.00 | 1,344,405 |
| 06/06/2022 | AAP | 890 | Indirect | COM | $1.01 | $898.90 | 1,339,405 |
| 06/02/2022 | AAP | 170 | Indirect | COM | $0.97 | $164.90 | 1,338,515 |
| 06/02/2022 | AAP | 4,830 | Indirect | COM | $0.98 | $4,733.40 | 1,338,345 |
| 03/31/2022 | AAP | 15,000 | Indirect | COM | $1.64 | $24,534.00 | 1,333,515 |
| 03/17/2022 | AAP | 5,000 | Indirect | COM | $1.59 | $7,950.00 | 1,318,515 |
| 03/15/2022 | AAP | 25,000 | Indirect | COM | $1.47 | $36,650.00 | 1,313,515 |
| 08/20/2021 | AAP | 10,000 | Indirect | COM | $1.93 | $19,254.00 | 1,288,515 |
| 05/04/2021 | AAP | 35,714 | Direct | COM | $2.80 | $99,999.20 | 35,714 |
| 02/17/2021 | AAP | 100,000 | Indirect | COM | $3.50 | $350,000.00 | 1,278,515 |
| 11/13/2019 | AAP | 14,736 | Indirect | COM | $3.00 | $44,240.42 | 1,178,515 |
| 11/12/2019 | AAP | 272 | Indirect | COM | $2.90 | $788.80 | 1,163,779 |
| 08/07/2019 | AAP | 2,500 | Indirect | COM | $3.54 | $8,850.00 | 1,163,507 |
| 08/06/2019 | AAP | 5,000 | Indirect | COM | $3.58 | $17,875.00 | 1,161,007 |
| 06/14/2019 | AAP | 11,657 | Indirect | COM | $3.40 | $39,666.44 | 1,156,007 |
| 06/13/2019 | AAP | 343 | Indirect | COM | $3.52 | $1,207.36 | 1,144,350 |
| 06/11/2019 | AAP | 6,000 | Indirect | COM | $3.67 | $22,020.00 | 1,144,007 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research